000788.SZ · 北大医药
China A-shares · RS rating 71 · As of 2026-10-14
| Price | 5.50 CNY |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 71 / 75 / 72 / 60 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 28 / 20 / 33 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +7.8% |
| Distance from 52-week high | +26.9% |
| Market cap (USD) | $505.4M |